PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-1.19%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$828M
AUM Growth
+$828M
(-14%)
Cap. Flow
-$45M
Cap. Flow
% of AUM
-5.44%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
264
New
28
Increased
49
Reduced
25
Closed
53
Top Buys
| 1 |
Biogen
BIIB
|
$31M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 3 |
C4 Therapeutics
CCCC
|
$14.4M |
| 4 |
Bio-Techne
TECH
|
$10.8M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$10.7M |
Top Sells
| 1 |
Natera
NTRA
|
$22M |
| 2 |
The Beauty Health Co
SKIN
|
$14.4M |
| 3 |
DexCom
DXCM
|
$14.1M |
| 4 |
ICU Medical
ICUI
|
$13.9M |
| 5 |
LivaNova
LIVN
|
$12.9M |
Sector Composition
| 1 | Healthcare | 89.68% |
| 2 | Materials | 1.3% |
| 3 | Industrials | 0.61% |
| 4 | Consumer Discretionary | 0.26% |
| 5 | Financials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Universe Pharmaceuticals
UPC
$2.11M
| $1.37M | 0.04% |
1,079,437
-35,648
| -3% | -$45.5K |
|
77
Adicet Bio
ACET
$60.8M
| $1.33M | 0.04% |
66,626
-70,182
| -51% | -$1.4M |
|
|
BHVN
78
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.3M | 0.04% |
10,985
+100
| +0.9% | +$11.9K |
|
79
Agilon Health
AGL
$497M
| $1.14M | 0.04% |
45,000
-186,197
| -81% | -$4.72M |
|
80
Nautilus Biotechnolgy
NAUT
$80.7M
| $1.06M | 0.03% |
244,698
+100,900
| +70% | +$438K |
|
81
Orchestra BioMed
OBIO
$147M
| $1.03M | 0.03% |
104,026
+500
| +0.5% | +$4.96K |
|
|
GBT
82
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.02M | 0.03% |
+29,454
| New | +$1.02M |
|
83
Cyclerion Therapeutics
CYCN
$7.75M
| $862K | 0.03% |
776,497
+4,800
| +0.6% | +$5.33K |
|
84
Corvus Pharmaceuticals
CRVS
$419M
| $813K | 0.03% |
495,484
+3,100
| +0.6% | +$5.09K |
|
85
Gossamer Bio
GOSS
$587M
| $763K | 0.02% |
87,929
+500
| +0.6% | +$4.34K |
|
|
MDVL
86
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $693K | 0.02% |
714,120
| – | – |
|
87
Disc Medicine
IRON
$2.14B
| $690K | 0.02% |
496,120
+3,100
| +0.6% | +$4.3K |
|
88
Tango Therapeutics
TNGX
$745M
| $627K | 0.02% |
82,727
+500
| +0.6% | +$3.79K |
|
|
RCOR
89
DELISTED
Renovacor, Inc.
RCOR
| $616K | 0.02% |
145,390
-5,115
| -3% | -$21.7K |
|
90
TherapeuticsMD
TXMD
$12.7M
| $615K | 0.02% |
+1,619,080
| New | +$615K |
|
91
KalVista Pharmaceuticals
KALV
$713M
| $610K | 0.02% |
41,393
+306
| +0.7% | +$4.51K |
|
92
Acumen Pharmaceuticals
ABOS
$84.2M
| $568K | 0.02% |
145,195
+19,135
| +15% | +$74.9K |
|
93
Xenon Pharmaceuticals
XENE
$2.99B
| $459K | 0.01% |
15,002
-33,500
| -69% | -$1.02M |
|
94
Pyxis Oncology
PYXS
$91.2M
| $458K | 0.01% |
113,362
+600
| +0.5% | +$2.42K |
|
|
VINC
95
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $434K | 0.01% |
108,459
+300
| +0.3% | +$1.2K |
|
|
SLGCW
96
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $413K | 0.01% |
204,401
| – | – |
|
97
Relmada Therapeutics
RLMD
$48.8M
| $402K | 0.01% |
14,885
+100
| +0.7% | +$2.7K |
|
98
Enliven Therapeutics
ELVN
$1.24B
| $370K | 0.01% |
196,635
+1,100
| +0.6% | +$2.07K |
|
|
CSII
99
DELISTED
Cardiovascular Systems, Inc.
CSII
| $247K | 0.01% |
+10,911
| New | +$247K |
|
100
Cyclacel Pharmaceuticals
CYCC
$17.2M
| $237K | 0.01% |
77,568
-24,756
| -24% | -$64.6K |
|